Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.37 +0.00 (+0.16%)
At close: Nov 11, 2026 · 4:00 PM EST

Tenaya Therapeutics (TNYA) Cash & Equivalents (2020 - 2026)

Updated

Tenaya Therapeutics (TNYA) reported Cash & Equivalents of $66.8 million for Q3 2026, up 18.6% from $56.31 million a year earlier but down 14.5% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Tenaya Therapeutics posted Cash & Equivalents of $100.55 million.

  • Cash & Equivalents has a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $4.32 million in FY2024 (-90.5%), $45.68 million in FY2023 (-52.1%), $95.27 million in FY2022 (+149.9%) and $38.13 million in FY2021 (-70.3%).
  • Five-year quarterly Cash & Equivalents spans a low of $4.32 million in Q4 2024 and a high of $100.55 million in Q4 2025.
  • Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 83.7% over the last seven quarters.
  • The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 584.1%); the low point was Q4 2024 (a decline of 90.5%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $78.09 million (Q2 2026), $80.89 million (Q1 2026) and $100.55 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Tenaya Therapeutics 84.33 Mn 17.53 Mn - 66.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 66.80 Mn
Jun 30, 2026 78.09 Mn
Mar 31, 2026 80.89 Mn
Dec 31, 2025 100.55 Mn
Sep 30, 2025 56.31 Mn
Jun 30, 2025 62.67 Mn
Mar 31, 2025 53.77 Mn
Dec 31, 2024 4.32 Mn
Sep 30, 2024 8.23 Mn
Jun 30, 2024 58.13 Mn
Mar 31, 2024 59.30 Mn
Dec 31, 2023 45.68 Mn
Sep 30, 2023 82.15 Mn
Jun 30, 2023 75.57 Mn
Mar 31, 2023 72.54 Mn
Dec 31, 2022 95.27 Mn
Sep 30, 2022 34.49 Mn
Jun 30, 2022 31.01 Mn
Mar 31, 2022 25.97 Mn
Dec 31, 2021 38.13 Mn
API Access

Tenaya Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TNYA&period=max&api_key=YOUR_API_KEY